GlassScriptPhysician profile
Beth A Bretz
NPI 1376969600
$7,641.65
in general payments reported to CMS, 2019-2025
35 companies · $1,480 in 2025
The $1,480 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,486 · 2022: $1,515 · 2023: $1,431 · 2024: $1,730 · 2025: $1,480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,640.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,453.98 | 2021-2025 | |
| Novo Nordisk INC | $1,443.72 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $628.55 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $588.09 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $470.16 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $325.45 | 2021-2025 | |
| Xeris Pharmaceuticals, INC. | $291.76 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $283.68 | 2024-2025 | Rexulti |
| Exact Sciences Corporation | $244.46 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $224.56 | 2021-2025 | Invega Sustenna |
| Abbott Laboratories | $223.59 | 2022-2023 | Freestyle Libre 2, Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $214.28 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astellas Pharma US INC | $190.39 | 2021-2024 | Veozah |
| Merck Sharp & Dohme LLC | $159.23 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| Aimmune Therapeutics, INC. | $115.96 | 2024-2025 | Zenpep |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Bretz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.